Seek Returns

BIO.B vs. ELAN: Bio-Rad Laboratories vs. Elanco Animal Health Stock Comparison

How do Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but BIO.B is classified in Life Sciences Tools & Services while ELAN is classified in Pharmaceuticals.

Company profile comparison for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
Profile ItemBIO.BELAN
NameBio-Rad Laboratories, Inc. Class B Common StockElanco Animal Health Incorporated
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesPharmaceuticals
GICS Sub-IndustryLife Sciences Tools & ServicesPharmaceuticals
Market Capitalization10.49 billion USD13.39 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateSeptember 21, 1999September 20, 2018
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

BIO.B
ELAN
GSPC
Loading price history…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Total Return (1Y)27.69%21.78%
Total Return (3Y, Annualized)9.13%36.41%
Total Return (5Y, Annualized)-12.33%-4.11%

Risk Profile

Drawdown History

BIO.B
ELAN
GSPC
Loading price history…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Elanco Animal Health (ELAN) trades around 5.33M shares per day on average, while Bio-Rad Laboratories (BIO.B) sees only 11 — a volume gap that can matter for position sizing, exit liquidity, and order execution.

Risk profile metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Volatility (1Y, Annualized)30.96%43.35%
Beta (5Y)1.001.70
Max Drawdown (5Y)-70.74%-75.02%
Avg. Volume (3M)115.33M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
BIO.B and ELAN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Sharpe Ratio (1Y)0.740.40
Sortino Ratio (1Y)1.100.58

Profitability

ROE (TTM)

Elanco Animal Health (ELAN) reports a negative ROE of -2.20%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Bio-Rad Laboratories (BIO.B) reports 14.27%, ranking against industry peers normally.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.27%

Max
109.18%
BIO.B
14.27%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.20%

Max
109.18%
Q3
6.23%
ELAN
-2.20%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile Bio-Rad Laboratories (BIO.B) reports 39.45%, ranking against industry peers normally.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.45%

BIO.B
39.45%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both Bio-Rad Laboratories (BIO.B) at 9.46% and Elanco Animal Health (ELAN) at 7.71% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.46%

Max
83.12%
Q3
14.77%
BIO.B
9.46%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.71%

Max
83.12%
Q3
14.77%
ELAN
7.71%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
ROE (TTM)14.27%-2.20%
ROA (TTM)1.50%1.85%
Net Margin (TTM)39.45%-2.86%
Operating Margin (TTM)9.46%7.71%
Gross Margin (TTM)52.19%56.18%

Growth

Revenue Growth

Both Bio-Rad Laboratories (BIO.B) at 0.65% and Elanco Animal Health (ELAN) at 6.22% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Elanco Animal Health (ELAN) reports EPS growth of -169.12%, ranked against its industry; Bio-Rad Laboratories (BIO.B) has no EPS growth figure this period.

Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Revenue Growth (YoY)0.65%6.22%
Revenue Growth (3Y CAGR)-2.68%2.25%
EPS Growth (YoY)---169.12%
EPS Growth (3Y CAGR)----

Financial Strength

Current Ratio (MRQ)

Bio-Rad Laboratories (BIO.B) at 3.18 keeps current ratio within its industry’s typical mid-range, while Elanco Animal Health (ELAN) at 2.09 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ELAN.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.18

Max
25.13
Q3
12.13
Median
5.52
BIO.B
3.18
Q1
2.47
Min
0.10

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.09

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ELAN
2.09
Min
0.10
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both Bio-Rad Laboratories (BIO.B) at 0.18 and Elanco Animal Health (ELAN) at 0.61 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.18

Max
1.42
Q3
0.65
BIO.B
0.18
Median
0.15
Q1
0.02
Min
0.00

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.61

Max
1.42
Q3
0.65
ELAN
0.61
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Current Ratio (MRQ)3.182.09
Debt / Equity (MRQ)0.180.61
Net Debt / EBITDA-0.733.33

Dividends

Dividend Yield (TTM)

Neither Bio-Rad Laboratories (BIO.B) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BIO.B
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Bio-Rad Laboratories (BIO.B) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BIO.B
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Bio-Rad Laboratories (BIO.B) trades at 10.36 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.36

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
BIO.B
10.36
Min
0.07

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): ELAN does not report P/E ratio, so it has no value marker; BIO.B is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Elanco Animal Health (ELAN) at 2.60 sits in the cheaper P/S ratio quartile while Bio-Rad Laboratories (BIO.B) at 4.05 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.05

Max
58.18
Q3
25.77
Median
7.30
BIO.B
4.05
Q1
3.01
Min
0.01

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.60

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.60
Min
0.01
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Bio-Rad Laboratories (BIO.B) at 1.38 sits in the lower P/B ratio quartile against book while Elanco Animal Health (ELAN) at 2.02 is valued near its industry’s middle — BIO.B is cheaper on assets, though weigh it against ROE and asset quality.

BIO.B

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.38

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
BIO.B
1.38
Min
-5.59

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.02

Max
13.53
Q3
6.54
Median
3.25
ELAN
2.02
Q1
1.69
Min
-5.59
Loading chart…
Bio-Rad Laboratories (BIO.B) vs. Elanco Animal Health (ELAN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Bio-Rad Laboratories (BIO.B) and Elanco Animal Health (ELAN)
MetricBIO.BELAN
P/E Ratio (TTM)10.36--
P/S Ratio (TTM)4.052.60
P/B Ratio (MRQ)1.382.02
Free Cash Flow Yield (TTM)2.59%5.12%